
MRI machine kills man wearing 9 kg metal necklace in New York
"At that instant, the machine switched him around, pulled him in, and he hit the MRI," McAllister recounted. "He waved goodbye to me and then his whole body went limp."She said both she and the technician tried to pry her husband away from the magnet. "I'm saying, 'Could you turn off the machine? Call 911. Do something. Turn this damn thing off!'"McAllister also noted that this wasn't their first visit to the facility, nor was it the first time staff members had seen her husband's chain. She recalled a prior exchange with an employee who had previously commented on the chain, saying, "Oh, that's a big chain."The facility, Nassau Open MRI, has not issued a public comment. The investigation is ongoing.In 2018, an Indian man died after being pulled into an MRI machine while visiting a relative at a Mumbai hospital, police said at the time.Rajesh Maru, 32, was dragged into the machine by its powerful magnetic force after entering the MRI room with an oxygen cylinder, according to a police statement, according to a report by The Guardian.THE REASON BEHIND KEITH'S DEATHMRI machines use strong magnetic fields to produce detailed internal images of the body. Because of their intensity, they can turn metal objects into high-speed projectiles.Patients and anyone entering the MRI room are typically required to remove all metallic items, including jewellery, clothing with metal components, phones, and even hairpins.The US Food and Drug Administration (FDA) has long warned about the dangers posed by metal objects around MRI machines. Even small items such as keys or phones can become dangerous projectiles.advertisementMetal in a room that has the magnet will fly across the room to the scanner, to this large magnet, and will really hit anything in its way, Dr Rebecca Smith-Bindman, a radiologist, told CNN in 2011."So within radiology training, one learns very early that that's not OK, that you can't have external metal in the room, and you can't have metal in the patient," she said, adding "That could lead to a problem."- Ends

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Time of India
2 hours ago
- Time of India
With more AI pilots reporting sick after Gujarat crash, DGCA issues circular on mental health
With more AI pilots reporting sick after Gujarat crash, DGCA issues circular on mental health NEW DELHI: Air India has reported an increase in sick leaves by pilots in the aftermath of the AI-171 crash on June 12, prompting Directorate General of Civil Aviation (DGCA) to ask airlines to take steps for mental wellbeing of crew members. "Air India's 112 pilots, comprising 51 commanders and 61 first officers, reported sick on June 16... DGCA has already issued a medical circular regarding mental health of flight crews and air traffic controllers," MoS for civil aviation Murlidhar Mohol told Lok Sabha had earlier this month directed Indian carriers, particularly the major ones like Air India and IndiGo, to hold a post-trauma mental health workshop for their flight crew. Several pilots, especially of Boeing 787 that crashed in Ahmedabad last month, have been reporting trauma after the accident. "The conversation in cockpits these days is mostly limited to what could have caused the crash. What is it that really went wrong? That is really eating us up. We are not buying the pilot suicide theory that has been fuelled by AAIB's extremely questionable preliminary report," said multiple pilots. The DGCA medical circular advises "quick and effective methods to assess mental health that can easily be performed by DGCA empanelled medical examiners, and the introduction of a separate, standalone and customised training capsule for the flight crew/ATCOs to recognise and manage the adverse effects of mental health conditions".


Time of India
5 hours ago
- Time of India
Pharma, medical device sectors receive right prescription
This is a representative AI image The India-UK FTA is expected to strengthen supply chains for pharma and medical devices sectors, improve access to affordable medicines, and pave the way for collaboration in bulk drugs and joint research. The domestic pharma industry is hopeful exports of generic drugs to UK - currently valued at around $1 billion - will see a boost. Sudarshan Jain, secretary general, Indian Pharmaceutical Alliance, said the pact offers opportunities to supply affordable and quality-assured medicines, contributing to better patient care in the UK. Namit Joshi, chairman of Pharmexcil, added the agreement paves the way for partnerships in bulk drug imports, CDMO, and joint research, strengthening India's competitive edge. The medical devices industry also expects bilateral trade to accelerate. "Earlier, devices imported into UK were duty-free, so tariffs weren't a concern. But regulatory approval costs & timelines were. We had sought UK recognition of Indian CDSCO or QCI certifications to fast-track approvals," said Rajiv Nath, forum coordinator, AiMeD. He highlighted need for stricter Rules of Origin checks to prevent misuse of FTA. Stay informed with the latest business news, updates on bank holidays and public holidays . AI Masterclass for Students. Upskill Young Ones Today!– Join Now


Time of India
7 hours ago
- Time of India
Duty relief to boost pharma companies' access to UK drug stores
Live Events (You can now subscribe to our (You can now subscribe to our Economic Times WhatsApp channel The India-UK FTA is expected to give a strong tailwind to India's pharmaceutical and medical devices sectors with tariff relief and smoother regulatory pathways acting as critical drivers, industry experts told agreement will boost exports giving an easier access to the UK market. It is expected to help Indian companies - especially those in generics and biosimilars - to scale their market presence, fast track product approvals, provide a push to cross-border R&D and UK has committed to zero tariff on nearly 99% of Indian pharma exports. While Indian pharma exports to the UK were largely duty free even earlier, the latest agreement formalises the status which brings in long-term clarity to to industry estimates, the pharma market size of the UK stands at about $45 billion and is expected to shoot to $73 billion by 2033. The share of the Indian drugs can see a significant push from the UK's generics segment which is currently pegged at $5 pharmaceutical exports to the UK crossed $910 million in FY24, according to estimates."The agreement strengthens supply chains , enhances access to affordable medicines , and drives Foreign Direct Investment (FDI)," said Namit Joshi, Chairman of Pharmexcil."This partnership paves the way for collaborations in bulk drug imports, CDMO (contract manufacturing), and joint research, empowering India's competitive edge and promoting global partnerships."The pact will open up trade and economic opportunities between the two countries. "The pharma sector will have opportunities to supply quality medicines contributing to better patient care in the UK," said Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance."The tariffs relief on generic medicines and key medical devices like surgical instruments and diagnostics under the FTA will enhance the affordability and appeal of Indian products in the UK market," said Manoj Mishra, Partner and Tax Controversy Management Leader, Grant Thornton Bharat. The move significantly boosts the competitiveness of Indian generics and high-quality affordable healthcare solutions, positioning India to scale its footprint in one of Europe's most valuable healthcare markets, said the medical devices sector too the move is expected to open new opportunities, said experts.